Digitisation | June 03, 2021
Lupin to foray into the digital healthcare space
The company recently incorporated a new entity in the name of Lupin Digital Health Limited
The company recently incorporated a new entity in the name of Lupin Digital Health Limited
The company has registered total income of Rs. 3,847 crores for Q4 FY21, up by 3% on a y-o-y basis from Rs. 3,752 crores registered during corresponding period of the previous year
Allecra Therapeutics would now either directly or through out license file for NDA of this molecule.
The progress has been encouraging with approvals and launches in the US, EU, Japan, Australia and Emerging Markets. Post Mylan Upjohn (Pfizer) merger, the scope has been extended to China as well.
New agreement for three further production lines at Lonza’s site in Visp, Switzerland
The U.S. Development Finance Corporation is funding a substantial expansion of manufacturing capability for BioE, the vaccine manufacturer in India
Lonza's Ibex Design end-to-end offering will cover the development stages of IMT-009 from development candidates through early clinical studies
PegIFN in COVID19 has several add-on advantages compared to other anti-viral agents
_256_384.jpg)
The company expects to generate an EBITDA margin before special items of around 27 percent in 2021.
Promising drug pipeline, focus on gene therapy and innovative digital health solutions will remain the key pillars of Bayer’s pharmaceutical business
Subscribe To Our Newsletter & Stay Updated
